Hangzhou, China · Founded 2014 · Privately Held (backing)
Developer of innovative drugs intended for the treatment of tumors and immune diseases. iMBIORAY is based in Hangzhou, China and was founded in 2014. It has raised $90.9 million.
Last price · $/share
—
Implied valuation
—
Total raised
$90.9M
Last round
—
Team — not yet on record
No current team members for iMBIORAY are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of iMBIORAY with a free account
·The complete investor list: 15 names
·Watch iMBIORAY: the Monday email on marks, rounds and moves
